Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. (AVTE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
avte · stock forecast · 8 analysts (3M) · FMP · updated Feb 3, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Hold
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$35.00
Consensus
$13.00
-86.1% upside
Low
$2.00
Median: $2 · Last Close: $93.80
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$13.00
-86.1% upside
High Target
$35
-62.7%
Low Target
$2
-97.9%
Current Price
$93.80
as of today
Based on analyst price targets, the AVTE stock price prediction for the next 12 months ranges from $2 to $35. The consensus AVTE price forecast of $13.00 implies -86.1% upside from the current price of $93.80.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $95.58 | ↑ 1.89% |
1-day model range: $95–$96.15. Peak: $96.15 (+1.89%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · AVTE · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-06-18 | Evercore ISI Group | Downgrade ↓ | Outperform→In Line |
| 2024-06-18 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2024-06-18 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2024-06-18 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2024-06-17 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2024-06-17 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2024-06-06 | Wedbush | Maintains | Outperform→Outperform |
| 2024-05-22 | Wedbush | Maintains | Outperform→Outperform |
| 2024-05-14 | Wedbush | Maintains | Outperform→Outperform |
| 2024-04-01 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Aerovate Therapeutics, Inc. (AVTE) stock. Of the recent 20 rating actions, 2 were upgrades and 8 were downgrades. 8 analysts currently cover AVTE.
Analyst Recommendation Trends
AVTE analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$20M
EPS This Year
$-0.65
EPS Next Year
$-0.79
↑ 21.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast AVTE EPS of $-0.65 for the current fiscal year, based on estimates from 2 analysts. The AVTE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AVTE stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AVTE price target is $13.00 (-86.1% upside), with an analyst consensus of Hold.
The AVTE short-term stock prediction for tomorrow is $95.58 (+1.89%).
Aerovate Therapeutics, Inc. trades on NASDAQ under the ticker AVTE. The AVTE stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 25% of covering analysts.
Frequently asked questions
AVTE forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month AVTE price target is $13.00, with a high forecast of $35.00 and a low of $2.00. The median price target is shown in the chart above when available. This implies -86.1% potential upside from the current price of $93.80.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.